The chirality selectivity in the uptake of platinum (II) complexes with 1,2-cyclohexanediamine isomers as carrier ligand by human erythrocytes

被引:12
作者
Zou, J
Yang, XG
Li, RC
Lu, JF
Wang, K
机构
[1] BEIJING MED UNIV,SCH PHARMACEUT SCI,DEPT INORGAN CHEM,BEIJING 100083,PEOPLES R CHINA
[2] NANJING UNIV,INST COORDINAT CHEM,STATE KEY LAB COORDINAT CHEM,NANJING 210008,PEOPLES R CHINA
基金
中国国家自然科学基金;
关键词
chirality; 1,2-cyclohexanediamine; human erythrocyte; platinum complexes; uptake;
D O I
10.1023/A:1018314719904
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The uptake kinetics of cisplatin analogs of 1,2-cyclohexanediamine (dach) isomers with various leaving groups, by human erythrocytes in plasma isotonic buffer, were studied, The experimental results showed that the uptake rate constants (k values) decrease with the change of leaving group in the sequence: chloride (Cl) > squaric acid (SA)> oxalate (OX)> demethylcantharic acid (DA), with the same dach isomer as carrier group, It is noteworthy that for the platinum (II) complexes with the same leaving group, the k values always reduce as: 1R, 2R-dach > 1R, 2S-dach > 1S, 2S-dach, This result reflects the chirality selectivity, No differences in reactivity to protein thiols and effects on membrane permeability were found for the R,R-, R,S-, S,S-isomeric complexes, It is proposed that the chirality selectivity in uptake is due to the recognition of the chirality of the platinum complexes by the erythrocyte membrane. The interactions between the chiral platinum complexes and the head groups of the membrane phospholipid molecules are probably involved.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 17 条
[1]   PREPARATION AND CHEMICAL CHARACTERISTICS OF HEMOGLOBIN-FREE GHOSTS OF HUMAN ERYTHROCYTES [J].
DODGE, JT ;
HANAHAN, DJ ;
MITCHELL, C .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1963, 100 (01) :119-&
[2]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[3]   CELLULAR ACCUMULATION OF THE ANTICANCER AGENT CISPLATIN - A REVIEW [J].
GATELY, DP ;
HOWELL, SB .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1171-1176
[4]   CHARACTERIZATION OF (1,2-CYCLOHEXANEDIAMINE)PLATINUM(II) ISOMERS AND THEIR D(GPG) ADDUCTS BY MEANS OF H-1-NMR SPECTROSCOPY - A MINOR STRUCTURAL-CHANGE INDUCED BY THE ISOMERS [J].
INAGAKI, K ;
NAKAHARA, H ;
ALINK, M ;
KIDANI, Y .
INORGANIC CHEMISTRY, 1990, 29 (22) :4496-4500
[5]   DIFFERENCES IN BINDING OF (1,2-CYCLOHEXANEDIAMINE)PLATINUM(II) ISOMERS WITH D(GPG) [J].
INAGAKI, K ;
KIDANI, Y .
INORGANIC CHEMISTRY, 1986, 25 (01) :1-3
[6]   SPIN-LABELED NEUROSPORA MITOCHONDRIA [J].
KEITH, A ;
BULFIELD, G ;
SNIPES, W .
BIOPHYSICAL JOURNAL, 1970, 10 (07) :618-&
[7]  
KIDANI Y, 1991, PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY, P127
[8]  
KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111
[9]   A SPIN LABELING STUDY OF THE EFFECTS OF INORGANIC-IONS AND PH ON THE CONFORMATION OF SPECTRIN [J].
LAMMEL, B ;
MAIER, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 622 (02) :245-258
[10]  
Lu J F, 1995, Met Based Drugs, V2, P73, DOI 10.1155/MBD.1995.73